Achillion's CEO Milind Deshpande steps down; NeuroVision raises $11.2M for novel Alzheimer's detection tech
→ Milind Deshpande is stepping down from Achillion $ACHN, the biotech he’s led for the better part of the last two decades, first as CSO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
